IDH1 and glioblastoma: Previously, the diagnosis of glioblastomas relied on histological features, like microvascular proliferation or necrosis, encompassing both IDH-mutated (10%) and IDH wild-type (90%) tumors, each displaying markedly distinct biological natures and prognoses.